- Home
- GLMD vs SXTP Comparison
GLMD vs SXTP Comparison
Compare GLMD & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- SXTP
- Stock Information
- Founded
- GLMD 2000
- SXTP 2010
- Country
- GLMD Israel
- SXTP United States
- Employees
- GLMD N/A
- SXTP N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- GLMD Health Care
- SXTP Health Care
- Exchange
- GLMD Nasdaq
- SXTP Nasdaq
- Market Cap
- GLMD 3.0M
- SXTP 3.5M
- IPO Year
- GLMD 2014
- SXTP 2023
- Fundamental
- Price
- GLMD $1.51
- SXTP $2.92
- Analyst Decision
- GLMD Hold
- SXTP Buy
- Analyst Count
- GLMD 1
- SXTP 2
- Target Price
- GLMD N/A
- SXTP $7.00
- AVG Volume (30 Days)
- GLMD 255.6K
- SXTP 271.9K
- Earning Date
- GLMD 06-17-2025
- SXTP 05-15-2025
- Dividend Yield
- GLMD N/A
- SXTP N/A
- EPS Growth
- GLMD N/A
- SXTP N/A
- EPS
- GLMD N/A
- SXTP N/A
- Revenue
- GLMD N/A
- SXTP $802,323.00
- Revenue This Year
- GLMD N/A
- SXTP $95.50
- Revenue Next Year
- GLMD N/A
- SXTP $80.78
- P/E Ratio
- GLMD N/A
- SXTP N/A
- Revenue Growth
- GLMD N/A
- SXTP 118.37
- 52 Week Low
- GLMD $1.15
- SXTP $1.41
- 52 Week High
- GLMD $23.80
- SXTP $35.99
- Technical
- Relative Strength Index (RSI)
- GLMD 56.28
- SXTP 59.68
- Support Level
- GLMD $1.36
- SXTP $2.60
- Resistance Level
- GLMD $1.60
- SXTP $3.67
- Average True Range (ATR)
- GLMD 0.09
- SXTP 0.31
- MACD
- GLMD 0.03
- SXTP 0.08
- Stochastic Oscillator
- GLMD 79.07
- SXTP 56.52
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.